CHI3L1 and rheumatoid arthritis: Collectively, these findings highlight the central role of CHI3L1 in RA pathogenesis, suggesting that it not only promotes disease progression through modulation of inflammatory responses and synovial destruction but also holds promise as a molecular biomarker and therapeutic target with substantial translational potential.